Javier Cote-Sierra
Fondateur chez Allianthera Suzhou Biopharmaceutical Co Ltd
Profil
Javier Cote-Sierra has founded Allianthera Suzhou Biopharmaceutical Co Ltd in 2020, where he currently holds the position of Director & Chief Scientific Officer.
He previously worked at Pfizer Inc. as Senior Director-External Research & Development from 2015 to 2017, at Genzyme Corp.
as Head-Inflammation & Immunology External Innovation from 2018 to 2020, and will be Chief Scientific Officer at Zura Bio Ltd.
in 2023.
He also served as an Independent Director at JATT Acquisition Corp.
Dr. Cote-Sierra received his graduate and doctorate degrees from Université Libre de Bruxelles.
Postes actifs de Javier Cote-Sierra
| Sociétés | Poste | Début |
|---|---|---|
| Allianthera Suzhou Biopharmaceutical Co Ltd | Fondateur | 01/12/2020 |
Anciens postes connus de Javier Cote-Sierra
| Sociétés | Poste | Fin |
|---|---|---|
| ZURA BIO LIMITED | Directeur Technique/Scientifique/R&D | 14/04/2023 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2020 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2017 |
| JATT ACQUISITION CORP | Directeur/Membre du Conseil | - |
Formation de Javier Cote-Sierra
| Université Libre de Bruxelles | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ZURA BIO LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
JATT Acquisition Corp.
 JATT Acquisition Corp. Financial ConglomeratesFinance JATT Acquisition Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Someit Sidhu on March 10, 2021 and is headquartered in George Town, Cayman Islands. | Finance |
| Allianthera Suzhou Biopharmaceutical Co Ltd | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |